Nadia Verbruggen
Mechelen-bovelingen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis.
Journal: ERJ open research
Published: August 30, 2023
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Journal: JAMA
Published: May 09, 2023
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design.
Journal: Advances in therapy
Published: August 14, 2019
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).
Journal: BMJ open respiratory research
Published: February 21, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
Journal: The lancet. Diabetes & endocrinology
Published: December 18, 2018
Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: September 12, 2015
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: June 04, 2014
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: October 11, 2013
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026